Am J Hematol

• 

  Publication Venue For

  • Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors..  94:563-574. 2019
  • Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes. 2019
  • Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial..  93:1394-1401. 2018
  • Physician decision making in selection of second-line treatments in immune thrombocytopenia in children..  93:882-888. 2018
  • Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia..  93:E49-E52. 2018
  • Recognition of early mortality in multiple myeloma by a prediction matrix..  92:915-923. 2017
  • Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy..  90:139-143. 2015
  • Parent education and biologic factors influence on cognition in sickle cell anemia..  89:162-167. 2014
  • Antiphospholipid syndrome: laboratory testing and diagnostic strategies..  87 Suppl 1:S75-S81. 2012
  • Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes..  86:E70-E73. 2011
  • Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease..  85:36-40. 2010
  • Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study..  85:29-35. 2010
  • The excess burden of stroke in hospitalized adults with sickle cell disease..  84:548-552. 2009